reviewNature Reviews Drug DiscoveryMay 1, 2004Closed access

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

NFNapoleone FerraraKJKenneth J. HillanHGHans‐Peter GerberWNWilliam Novotny

Gene Therapy Laboratory · Molecular Oncology (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,591
total citations
FWCI
40.62
Percentile
100%
References
164
Citations per year

Authors

4

Topics & keywords

Topics
Keywords
  • Bevacizumab
  • Angiogenesis
  • Medicine
  • Vascular endothelial growth factor
  • Monoclonal antibody
  • Cancer research
  • Colorectal cancer
  • Cancer
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.